StockNews.com Begins Coverage on Cabot (NYSE:CBT)
StockNews.com began coverage on shares of Cabot (NYSE:CBT – Free Report) in a research note published on Thursday. The brokerage issued a buy rating on the specialty chemicals company’s stock. CBT has been the subject of several other reports. JPMorgan Chase & Co. increased their price target on Cabot from $68.00 to $70.00 and gave […]